The 2016 meeting of the International Aphasia Rehabilitation Conference will take place in London at City, University of London from the 14th – 16th December 2016. Find out more about the exciting aphasia research being presented, including research funded by the Stroke Association.
Beyond impaired language function, people with aphasia report a range of psychosocial health problems which negatively affect their wellbeing, including reduced confidence and social isolation. These psychosocial problems are not adequately addressed by healthcare services.
Pilot trial of devices to extract clot from occluded arteries (PISTE)
This year, the UK Stroke Assembly North event was held in Manchester. On day two, the morning plenary was all about stroke research, including how patients can get involved in shaping it.
Although stroke survivors have reported fatigue as a problem, previous estimates of the numbers of people affected have varied greatly – from one-quarter to almost three-quarters of stroke survivors.
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
Stroke survivors and healthcare professionals have identified problems with thinking and mood after stroke as some of the most important issues faced after a stroke. This Lectureship aims to test treatments to help stroke survivors with their cognitive (thinking) difficulties.
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.